Neuroprotection in a rabbit model of intraventricular haemorrhage by cyclooxygenase-2, prostanoid receptor-1 or tumour necrosis factor-alpha inhibition

Brain

Volumn 133, Issue 8, 2010, Pages 2264-2280

  Vinukonda, Govindaiah ^a   Csiszar, Anna ^b   Hu, Furong ^a   Dummula, Krishna ^a   Pandey, Nishi Kant ^a   Zia, Muhammad T ^a   Ferreri, Nicholas R ^a   Ungvari, Zoltan ^b   LaGamma, Edmund F ^a   Ballabh, Praveen ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF OKLAHOMA   (United States)

Author keywords

Celecoxib; Cyclooxygenase 2; Germinal matrix haemorrhage; Intraventricular haemorrhage; Premature rabbit pups; Prostanoid receptor; Tumour necrosis factor alpha

Indexed keywords

8 CHLORODIBENZ[B,F][1,4]OXAZEPINE 10(11H) CARBOXYLIC ACID 2 [1 OXO 3 (4 PYRIDINYL)PROPYL]HYDRAZIDE HYDROCHLORIDE; CASPASE 3; CASPASE 7; CASPASE 8; CASPASE 9; CELECOXIB; CYCLOOXYGENASE 2; CYTOKINE; ETANERCEPT; GLYCEROL; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 1BETA; MESSENGER RNA; PROSTAGLANDIN E2; PROSTANOID RECEPTOR; PROSTANOID RECEPTOR 1; SC 51089; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CASPASE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2 INHIBITOR; NEUROPROTECTIVE AGENT; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN E RECEPTOR 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN HEMORRHAGE; CELL DEATH; CELL INFILTRATION; CESAREAN SECTION; COGNITION; CONTROLLED STUDY; DISEASE SEVERITY; FOREBRAIN; GLIOSIS; INFLAMMATORY INFILTRATE; MYELINATION; NERVE CELL DEGENERATION; NEUROPROTECTION; NEWBORN; NONHUMAN; PREMATURITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABBIT; ULTRASOUND; ANIMAL; ANTAGONISTS AND INHIBITORS; BRAIN; BRAIN VENTRICLE; DISEASE MODEL; DRUG EFFECTS; INTRACRANIAL HEMORRHAGES; METABOLISM; MYELIN SHEATH; PATHOLOGY;

ANIMALS; ANIMALS, NEWBORN; BRAIN; CASPASES; CELL DEATH; CEREBRAL VENTRICLES; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; DINOPROSTONE; DISEASE MODELS, ANIMAL; GLIOSIS; INTERLEUKIN-1BETA; INTRACRANIAL HEMORRHAGES; MYELIN SHEATH; NEUROPROTECTIVE AGENTS; RABBITS; RECEPTORS, PROSTAGLANDIN E; TUMOR NECROSIS FACTOR-ALPHA; RECEPTORS, PROSTAGLANDIN E, EP1 SUBTYPE;

EID: 77957055340     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awq107     Document Type: Article

References (45)

1. Ahmad AS, Ahmad M, de Brum-Fernandes AJ, Dore S. Prostaglandin EP4 receptor agonist protects against acute neurotoxicity. Brain Res 2005; 1066: 71-77.
2. Ahmad AS, Saleem S, Ahmad M, Dore S. Prostaglandin EP1 receptor contributes to excitotoxicity and focal ischemic brain damage. Toxicol Sci 2006; 89: 265-270.
3. Ahmad M, Zhang Y, Liu H, Rose M, Graham SH. Prolonged opportunity for neuroprotection in experimental stroke with selective blockade of cyclooxygenase-2 activity. Brain Res 2009.
4. Alvarez-Soria MA, Largo R, Sanchez-Pernaute O, Calvo E, Egido J, Herrero-Beaumont G. Prostaglandin E2 receptors EP1 and EP4 are up-regulated in rabbit chondrocytes by IL-1beta, but not by TNFalpha. Rheumatol Int 2007; 27: 911-917.
5. Araki E, Forster C, Dubinsky JM, Ross ME, Iadecola C. Cyclooxygenase-2 inhibitor ns-398 protects neuronal cultures from lipopolysaccharideinduced neurotoxicity. Stroke 2001; 32: 2370-2375.
6. Ballabh P, Xu H, Hu F, Braun A, Smith K, Rivera A, et al. Angiogenic inhibition reduces germinal matrix hemorrhage. Nat Med 2007; 13: 477-485.
7. Bilak M, Wu L, Wang Q, Haughey N, Conant K, St Hillaire C, et al. PGE2 receptors rescue motor neurons in a model of amyotrophic lateral sclerosis. Ann Neurol 2004; 56: 240-248.
8. Brambilla R, Burnstock G, Bonazzi A, Ceruti S, Cattabeni F, Abbracchio MP. Cyclo-oxygenase-2 mediates P2Y receptor-induced reactive astrogliosis. Br J Pharmacol 1999; 126: 563-567. (Pubitemid 29087831)
9. Braun A, Xu H, Hu F, Kocherlakota P, Siegel D, Chander P, et al. Paucity of pericytes in germinal matrix vasculature of premature infants. J Neurosci 2007; 27: 12012-12024.
10. Broughton BR, Reutens DC, Sobey CG. Apoptotic mechanisms after cerebral ischemia. Stroke 2009; 40: e331-9.
11. Brouwer A, Groenendaal F, van Haastert IL, Rademaker K, Hanlo P, de Vries L. Neurodevelopmental outcome of preterm infants with severe intraventricular hemorrhage and therapy for post-hemorrhagic ventricular dilatation. J Pediatr 2008; 152: 648-654.
12. Cai Z, Lin S, Pang Y, Rhodes PG. Brain injury induced by intracerebral injection of interleukin-1beta and tumor necrosis factor-alpha in the neonatal rat. Pediatr Res 2004; 56: 377-384.
13. Candelario-Jalil E, Fiebich BL. Cyclooxygenase inhibition in ischemic brain injury. Curr Pharm Des 2008; 14: 1401-1418.
14. Chu K, Jeong SW, Jung KH, Han SY, Lee ST, Kim M, et al. Celecoxib induces functional recovery after intracerebral hemorrhage with reduction of brain edema and perihematomal cell death. J Cereb Blood Flow Metab 2004; 24: 926-933.
15. Chua CO, Chahboune H, Braun A, Dummula K, Chua CE, Yu J, et al. Consequences of intraventricular hemorrhage in a rabbit pup model. Stroke 2009; 40: 3369-3377.
16. Cimino PJ, Keene CD, Breyer RM, Montine KS, Montine TJ. Therapeutic targets in prostaglandin E2 signaling for neurologic disease. Curr Med Chem 2008; 15: 1863-1869.
17. Crisafulli C, Galuppo M, Cuzzocrea S. Effects of genetic and pharmacological inhibition of TNF-alpha in the regulation of inflammation in macrophages. Pharmacol Res 2009; 60: 332-340.
18. Derrick M, Luo NL, Bregman JC, Jilling T, Ji X, Fisher K, et al. Preterm fetal hypoxia-ischemia causes hypertonia and motor deficits in the neonatal rabbit: a model for human cerebral palsy? J Neurosci 2004; 24: 24-34.
19. FitzGerald GA. COX-2 and beyond: approaches to prostaglandin inhibition in human disease. Nat Rev Drug Discov 2003; 2: 879-890.
20. Georgiadis P XH, Chua C, Hu F, Collins L, Huynh C, LaGamma EF, et al. Characterization of acute brain injuries and neurobehavioral profiles in a rabbit model of germinal matrix hemorrhage. Stroke 2008; 39: 3378-3388.
21. Gopez JJ, Yue H, Vasudevan R, Malik AS, Fogelsanger LN, Lewis S, et al. Cyclooxygenase-2-specific inhibitor improves functional outcomes, provides neuroprotection, and reduces inflammation in a rat model of traumatic brain injury. Neurosurgery 2005; 56: 590-604.
22. Gordon PH, Cheung YK, Levin B, Andrews H, Doorish C, Macarthur RB, et al. A novel, efficient, randomized selection trial comparing combinations of drug therapy for ALS. Amyotroph Lateral Scler 2008; 9: 212-222.
23. Hallenbeck JM. The many faces of tumor necrosis factor in stroke. Nat Med 2002; 8: 1363-1368.
24. Heuchan AM, Evans N, Henderson Smart DJ, Simpson JM. Perinatal risk factors for major IVH in the Australian and New Zealand Neonatal Network, 1995-1997. Arch Dis Child Fetal Neonatal Ed 2002; 86: F86-90.
25. Hosomi N, Ban CR, Naya T, Takahashi T, Guo P, Song XY, et al. Tumor necrosis factor-alpha neutralization reduced cerebral edema through inhibition of matrix metalloproteinase production after transient focal cerebral ischemia. J Cereb Blood Flow Metab 2005; 25: 959-967.
26. Hua Y, Wu J, Keep RF, Nakamura T, Hoff JT, Xi G. Tumor necrosis factor-alpha increases in the brain after intracerebral hemorrhage and thrombin stimulation. Neurosurgery 2006; 58: 542-50; discussion 542-550.
27. Hwang SY, Jung JS, Kim TH, Lim SJ, Oh ES, Kim JY, et al. Ionizing radiation induces astrocyte gliosis through microglia activation. Neurobiol Dis 2006; 21: 457-467.
28. Investigators of the Vermont-Oxford Trial Network Database Project. The Vermont-Oxford Trials Network: very low birth weight outcomes for 1990. Pediatrics 1993; 91: 540-545.
29. Ikawa H, Kameda H, Kamitani H, Baek SJ, Nixon JB, Hsi LC, et al. Effect of PPAR activators on cytokine-stimulated cyclooxygenase-2 expression in human colorectal carcinoma cells. Exp Cell Res 2001; 267: 73-80.
30. Kaur C, Ling EA. Periventricular white matter damage in the hypoxic neonatal brain: Role of microglial cells. Prog Neurobiol 2009; 87: 264-280.
31. Kawano T, Anrather J, Zhou P, Park L, Wang G, Frys KA, et al. Prostaglandin E2 EP1 receptors: downstream effectors of COX-2 neurotoxicity. Nat Med 2006; 12: 225-229.
32. Laemmli UK, Beguin F, Gujer-Kellenberger G. A factor preventing the major head protein of bacteriophage T4 from random aggregation. J Mol Biol 1970; 47: 69-85.
33. Manabe Y, Anrather J, Kawano T, Niwa K, Zhou P, Ross ME, et al. Prostanoids, not reactive oxygen species, mediate COX-2-dependent neurotoxicity. Ann Neurol 2004; 55: 668-675.
34. Martinet L, Fleury-Cappellesso S, Gadelorge M, Dietrich G, Bourin P, Fournie JJ, et al. A regulatory cross-talk between Vgamma9Vdelta2 T lymphocytes and mesenchymal stem cells. Eur J Immunol 2009; 39: 752-762.
35. Mayne M, Ni W, Yan HJ, Xue M, Johnston JB, Del Bigio MR, et al. Antisense oligodeoxynucleotide inhibition of tumor necrosis factoralpha expression is neuroprotective after intracerebral hemorrhage. Stroke 2001; 32: 240-248.
36. Minghetti L. Role of COX-2 in inflammatory and degenerative brain diseases. Subcell Biochem 2007; 42: 127-141.
37. Palladino MA, Bahjat FR, Theodorakis EA, Moldawer LL. Anti-TNFalpha therapies: the next generation. Nat Rev Drug Discov 2003; 2: 736-746.
38. Pompl PN, Ho L, Bianchi M, McManus T, Qin W, Pasinetti GM. A therapeutic role for cyclooxygenase-2 inhibitors in a transgenic mouse model of amyotrophic lateral sclerosis. FASEB J 2003; 17: 725-727.
39. Prevot A, Mosig D, Martini S, Guignard JP. Nimesulide, a cyclooxygenase- 2 preferential inhibitor, impairs renal function in the newborn rabbit. Pediatr Res 2004; 55: 254-260.
40. Sawyer T. Withdrawing support for withdrawing support from premature infants with severe intracranial hemorrhage. Pediatrics 2008; 121: 1071-2; author reply 1072-1073.
41. Shennan AH, Bewley S. Why should preterm births be rising? BMJ 2006; 332: 924-925.
42. Stephens BE, Vohr BR. Neurodevelopmental outcome of the premature infant. Pediatr Clin North Am 2009; 56: 631-46; table of contents.
43. Tobinick EL, Gross H. Rapid improvement in verbal fluency and aphasia following perispinal etanercept in Alzheimer's disease. BMC Neurol 2008; 8: 27.
44. Zhang X, Luhrs KJ, Ryff KA, Malik WT, Driscoll MJ, Culver B. Suppression of nuclear factor kappa B ameliorates astrogliosis but not amyloid burden in APPswe/PS1dE9 mice. Neuroscience 2009; 161: 53-58.
45. Zia MT, Csiszar A, Labinskyy N, Hu F, Vinukonda G, Lagamma EF, et al. Oxidative-nitrosative stress in a rabbit pup model of germinal matrix hemorrhage. Role of NAD(P)H oxidase. Stroke 2009; 40: 2191-2198